Continuous infusion, therapeutic drug monitoring and outpatient parenteral antimicrobial therapy with ceftazidime/avibactam: a retrospective cohort study

Véronique Goncette,Nathalie Layios,Julie Descy,Frédéric Frippiat

Journal of Global Antimicrobial Resistance（2021）

引用 22|浏览4

暂无评分

摘要

•Continuous infusion (CI) of β-lactams is increasingly recommended for serious infections.•CI of ceftazidime/avibactam (CAZ/AVI) allows high clinical and microbiological cure rates.•A therapeutic goal of ≥4–5 × MIC is achieved in plasma and/or at the site of infection.

查看译文

关键词

Ceftazidime/avibactam,Multidrug-resistant infection,Continuous infusion,Therapeutic drug monitoring,Outpatient parenteral antimicrobial therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要